|
Here you will find all departmental consultation activities listed by the main subject areas used on this Web site. These are the subjects used throughout the Health Canada Web site to group Health Canada information and are listed here so that you may search under each subject to find the Consultation activities occuring in that subject area.
 Current
Consumer and Clinical Radiation Protection Bureau Consultation
with Stakeholders on Draft Safety Code for Large Radiological Facilities
Past
Proposed Process for Amending the Cosmetic Ingredient Hotlist
Proposed Amendments to the Hazardous Products (Matches) Regulations
Proposed Technical Amendments to Schedule I to the Hazardous Products Act, the Hazardous Products (Expansion Gates and Expandable Enclosures) Regulations and the Playpens Regulations
Guidelines for Cosmetic Advertising and Labelling Claims
These guidelines are used extensively by both industry and government officials to assess the acceptability of cosmetic claims.
Proposed Regulations Amending the Hazardous Products (Glazed Ceramics and Glassware) Regulations
Stakeholder notification about proposed amendments.
Safety of Corded Window Covering Products
Health Canada is seeking the views of the Canadian public on a proposal that, under the Hazardous Products Act, would put in place legally binding requirements concerning window- covering products that are advertised, sold, or imported into Canada.
Update on proposed Cosmetic Ingredient Labelling Regulations
Health Canada would like to thank everyone who provided comments on the proposed Cosmetic Ingredient Labelling Regulations published in Canada Gazette Part I on March 27, 2004.
Additional information on this consultation:
Ingredient Listing - Proposed Amendment to the Cosmetic Regulations
Proposed Amendment to the Canadian Cosmetic Regulations
Current
E-consultation on Health Canada's "Blueprint for Renewal: Transforming Canada's Approach to Regulating Health Products and Food"Health Canada's Health Products and Food Branch (HPFB) has developed a 'Blueprint for Renewal' - a plan for modernizing and creating a more responsive regulatory system for health products and food. more...
Past
Policy on Public Input into the Review of Health Products
Review of Health Canada's Regulatory Framework for Clinical Trials
Public Forum on Breast Implants
Health Canada is currently reviewing the license applications of silicone gel-filled breast implants in Canada, with public input being an integral part of the Department's decision-making process. Health Canada has initiated a public forum to be held September 29-30, 2005 as part of its process for assessing the safety, risks, and benefits of silicone gel-filled breast implants.
Expert Advisory Panel Report
Development of Risk Management Strategy for Antimicrobial Resistance -- Consultation with Stakeholders
Focus on the report of Health Canada Advisory Committee on Animal Uses of Antimicrobials and Impact on Resistance and Human Health.
Draft Guidance for Industry on Management of Regulatory Submissions
The purpose of this document is to clarify the requirements for key steps in the process and enable drug sponsors to improve the quality of their submissions.
Draft Guidance for Industry on Preparation of Veterinary New Drug Submissions
The purpose of this document is to provide guidance for the preparation of a well-structured veterinary drug submission.
Draft Guidance for Industry -- Pharmaceutical Quality of Inhalation and Nasal Products
This document is intended to provide guidance to industry on the pharmaceutical quality of inhalation and nasal products to be authorized for marketing in Canada and/or in the European Union.
Consultation on proposed regulatory standards for e-prescribing in Canada
Health Protection Legislation Renewal -- Veterinary Drugs Discussion Document
A comprehensive review of the health protection system aimed at replacing outdated federal statutes that were developed decades ago in a piecemeal fashion.
Available Report
Measures to help ensure Canadians' continued access to an adequate supply of safe and affordable drugs (Internet Consultation)
Minister Dosanjh is reaffirming Health Canada's commitment to the health and safety of Canadians and Canada's drug system by proposing three measures to help protect Canada's drug supply and enhance consumer safety.
Maximum Residue Limits
Establishing Maximum Residue Limits (MRLS) for Altrenogest
Ongoing consultations to obtain feedback from stakeholders on proposed MRLs for Altrenogest. Feedback will be used for the promulgation of MRLs.
MedEffect Web site Consultations
To gather key stakeholder input for the development of the MedEffect portal, which allows centralized access to new safety information about marketed health products.
Options Analysis Paper will launch the stakeholder consultation process to provide input on which of three regulatory options and related arrangements stakeholders prefer
Proposal for Ceftiofur
Proposal for Danofloxacin
Proposal for Diclazuril
Proposal for Doramectin
Proposal for Enrofloxacin
Proposal for Eprinomectin
Proposal for Florfenicol
Proposal for Flunixin
Proposal for Ketoprofen (December 5, 2003)
Proposal for Ketoprofen (January 24, 2005)
Proposal for Lincomycin
Proposal for Melengestrol Acetate (MGA)
Proposal for Monensin
Proposal for Narasin
Proposal for Oxytetracycline
Proposal for Pirlimycin
Public Involvement Policy of the Veterinary Drugs Directorate (VDD)
VDD's strategic objective is to create an open, transparent, leading-edge, proactive organization that will enable its stakeholders, partners and the public to understand and contribute to VDD's priorities, capacity and performance while also contributing to VDD's statutory responsibilities as a regulator.
Consultations on the Registration and Disclosure of Clinical Trial Information
The feedback received will be used to help develop options for facilitating the registration and disclosure of clinical trial information.
Reprocessing of Single Use Medical Devices (SUDs)
Health Canada is currently undertaking consultations to develop a pan-Canadian strategy to manage the risks associated with the re-use of single-use medical devices.
Strengthening the Evaluation of Real World Drug Safety and Effectiveness
This working conference explores how to enhance the evaluation of the safety and effectiveness of drugs that are on the market. The conference will bring together federal, provincial and territorial officials, health care providers, patient representatives, the pharmaceutical industry and researchers.
Stakeholder's Workshop on the Review of Section 29.16 of the New Substance Notification Regulations (NSNRs)
The purpose of the activity is to engage and seek the views of interested parties on issues surrounding the effectiveness of s.29.16 of the NSNRs in protecting human health and the environment, and possible options to address them.
Selective COX-2 drugs: Expert Advisory Panel meeting and Public Forum
The Expert Advisory Panel on selective COX-2 non-steroidal anti-inflammatory drugs met in Ottawa on June 9 and 10, 2005. The first day consisted of a Public Forum where for the first time members of the public could present to a Health Canada expert panel. The second day was held in camera.
VICH Consultations
VICH is a trilateral (EU-Japan-USA) program aimed at harmonizing technical requirements for veterinary product registration.
Consultations -- Veterinary Drugs Directorate's Animal Tissue Form
Health Canada is seeking your comments on the development of an Animal Tissue Form that requests information on animal-sourced material used in the manufacture veterinary drugs.
Consultation on the Proposed Regulatory Framework for Whole Blood and Blood Components Intended for Transfusion.
Health Canada intends to consult with stakeholders in order to discuss and receive feedback on the proposed regulatory framework for whole blood and blood components intended for transfusion.
Second Round of External Stakeholder Consultations
Revised Draft Consumer Advertising Guidelines for Marketed Health Products (for Nonprescription Drugs including Natural Health Products)
Invitational Roundtable -- Risk Information Communication (Section 2.21) of the Revised Draft Consumer Advertising Guidelines for Marketed Health Products
Current
Haloacetic Acids in Drinking Water
The purpose of this consultation is to solicit comments on a proposed guideline, on the approach used for its development and on the potential economic costs of implementing it, as well as to determine the availability of additional exposure data.
Past
Radiological Characteristics of Drinking Water
For the past several years, the Federal-Provincial-Territorial Committee on Drinking Water (CDW) has been assessing the available information on radiological characteristics of drinking water with the intent of revising the existing guidelines for radionuclides in drinking water.
Proposal on Integrated Framework for Health-Related Components of CEPA DSL Categorization
To inform and obtain comment from stakeholder and general public regarding proposal content and options listed leading to an integrated Framework for Health-related Components of DSL Categorization.
Consultations with Targeted Stakeholders on National Guidelines for Environmental Assessment: Health Impacts of Noise.
Health Canada is developing national guidelines on this topic. The purpose of the March 31, 2006 consultation activity is to obtain input from targeted stakeholders on the working group's first draft.
Regional Strategic Plan on Aboriginal Health
Past
Online Consultation on Canada's Food Guide Revision
As part of Health Canada's ongoing efforts to consult Canadians on the proposed content of the revised Food Guide, an online consultation will be conducted from November 24, 2005 to January 12, 2006.
Addition of Vitamins and Minerals Policy Review and Implementation
This document is designed to help you provide us with your comments and, ultimately, influence the development of new regulations on addition of vitamins and minerals to foods for Canada.
Available Reports: Report 1, Report 2, Report 3
Dietary Guidance
To provide an update on proposed directions for national dietary guidance such as Nutrition Recommendations for Canadians, Canada's Guidelines for Healthy Eating and Canada's Food Guide to Healthy Eating.
2002 Consultations on Food Directorate Priorities and Actions
Natural Health Products Directorate (NHPD) Consultation on Fatty Acids and Essential Fatty Acids (EFAs)
Guidelines for the Safety Assessment of Novel Foods Derived from Plants and Microorganisms
These guidelines define the criteria and basic information requirements that must be considered in assessing the safety of novel whole foods and food constituents.
Health Canada's Food Directorate Regional Stakeholder Forum in Vancouver
Gain a better understanding of priority food safety and nutrition issues in the Western Region and what improvements may be required to the regulatory framework to better address those issues.
Labelling of Unpasteurized Fruit Juice / Cider
Thank you for participating in the consultation. The session closed on December 16, 2005 and Health Canada is now analyzing the responses. A summary of the analysis will be posted in Spring 2006, along with the next steps.
Multi-stakeholder Task Force on Trans Fat
Health Canada, in conjunction with the Heart and Stroke Foundation of Canada, works through a multi-stakeholder task force to develop recommendations and strategies for reducing trans fats in Canadian foods to the lowest level possible.
Natural Health Products Directorate (NHPD) Consultation on Fatty Acids and Essential Fatty Acids (EFAs)
In March 2005, the NHPD commissioned a discussion paper that focused on Canadian fatty acid and EFA research and
issues related to conducting fatty acid and EFA research in Canada. Following an extensive internet search and
interviews with key researchers, the need for more focused attention on EFAs within the context of natural health
products (NHPs) was identified, most notably in the area of partnership building and dissemination of information
on the NHP Regulations and the Natural Health Products Research Program (NHPRP).
Revision of Health Canada's Guidelines for the Safety Assessment of Novel Foods
The present consultation is intended to solicit comments on the revised Guidelines for the Safety Assessment of Novel Foods Derived from Plants and Microorganisms and on several issues related to the regulation of novel foods in Canada.
Current
Consultations with Stakeholders on Phase Two of the Federal Tobacco Control Strategy
Health Canada's Tobacco Control Programme invites stakeholders engaged in tobacco control issues in Canada to share their views concerning the second phase of the Federal Tobacco Control Strategy (FTCS).
Regional Discussions on the National Youth and Young Adult Framework for Action on Tobacco Control
Health Canada is working with the Provinces and Territories to develop a Youth and Young Adult Framework on Tobacco Control. This Framework will set out a long-term plan to help address the issue of tobacco use for people under thirty years of age.
Past
Request for comments on an issues paper regarding pre-implantation genetic diagnosis (PGD)
Proposal for New Health-related Information on Tobacco Product Labels
Consultation Paper
Regulatory Proposal To Include Warnings in Tobacco Advertisements
Consultation Paper
Available Report
Consultations with Tobacco C essation Quitline Stakeholders on a Proposed Minimum Dataset for Evaluation
Health Canada is proposing that all Canadian smoking cessation quitlines collect the same evaluation data for all callers.
Proposed regulations for the renewal of Health-related Information on Tobacco Product Labels under the Tobacco Act
Due to the recent federal election, this consultation has been suspended. This site will be updated as further information becomes available.
Proposed regulations to prohibit "light" and "mild" descriptors under the Tobacco Act
Due to the recent federal election, this consultation has been suspended. This site will be updated as further information becomes available.
Proposed regulatory amendment to the Tobacco Access Regulations
Due to the recent federal election, this consultation has been suspended. This site will be updated as further information becomes available.
.
|
